Cargando…

Programmed expression of pro-apoptotic BMCC1 during apoptosis, triggered by DNA damage in neuroblastoma cells

BACKGROUND: The multi-functional BMCC1 (BCH motif-containing molecule at the carboxyl terminal region 1)/PRUNE2 plays a clear role in suppression of tumor activity. In the patients with neuroblastoma (NB), reduced expression of BMCC1 in primary tumor tissues was associated with poor prognosis. By co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Islam, Mohammad Sazzadul, Takano, Ryo, Yokochi, Tomoki, Akter, Jesmin, Nakamura, Yohko, Nakagawara, Akira, Tatsumi, Yasutoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555734/ https://www.ncbi.nlm.nih.gov/pubmed/31170959 http://dx.doi.org/10.1186/s12885-019-5772-4

Ejemplares similares

BMCC1, which is an interacting partner of BCL2, attenuates AKT activity, accompanied by apoptosis
por: Tatsumi, Y, et al.
Publicado: (2015)

NLRR1 Is a Potential Therapeutic Target in Neuroblastoma and MYCN-Driven Malignant Cancers
por: Takatori, Atsushi, et al.
Publicado: (2021)

Identification of novel candidate compounds targeting TrkB to induce apoptosis in neuroblastoma
por: Nakamura, Yohko, et al.
Publicado: (2014)

Apoptotic Cell Death in Neuroblastoma
por: Li, Yuanyuan, et al.
Publicado: (2013)

ALK is a MYCN target gene and regulates cell migration and invasion in neuroblastoma
por: Hasan, Md. Kamrul, et al.
Publicado: (2013)

Bmcc1s, a Novel Brain-Isoform of Bmcc1, Affects Cell Morphology by Regulating MAP6/STOP Functions
por: Arama, Jessica, et al.
Publicado: (2012)

Co-Inhibition of the DNA Damage Response and CHK1 Enhances Apoptosis of Neuroblastoma Cells
por: Ando, Kiyohiro, et al.
Publicado: (2019)

Functional interplay between MYCN, NCYM, and OCT4 promotes aggressiveness of human neuroblastomas
por: Kaneko, Yoshiki, et al.
Publicado: (2015)

Oncogenic LMO3 Collaborates with HEN2 to Enhance Neuroblastoma Cell Growth through Transactivation of Mash1
por: Isogai, Eriko, et al.
Publicado: (2011)

BMCC1 Is an AP-2 Associated Endosomal Protein in Prostate Cancer Cells
por: Harris, Janelle L., et al.
Publicado: (2013)

How Do Telomere Abnormalities Regulate the Biology of Neuroblastoma?
por: Akter, Jesmin, et al.
Publicado: (2021)

Neuronal leucine-rich repeat 1 negatively regulates anaplastic lymphoma kinase in neuroblastoma
por: Satoh, Shunpei, et al.
Publicado: (2016)

Retrospective Analysis of INRG Clinical and Genomic Factors for 605 Neuroblastomas in Japan: A Report from the Japan Children’s Cancer Group Neuroblastoma Committee (JCCG-JNBSG) †
por: Ohira, Miki, et al.
Publicado: (2021)

EZH2 regulates neuroblastoma cell differentiation via NTRK1 promoter epigenetic modifications
por: Li, Zhenghao, et al.
Publicado: (2018)

Correlation between the International Neuroblastoma Pathology Classification and genomic signature in neuroblastoma
por: Nakazawa, Atsuko, et al.
Publicado: (2015)

Acceleration or Brakes: Which Is Rational for Cell Cycle-Targeting Neuroblastoma Therapy?
por: Ando, Kiyohiro, et al.
Publicado: (2021)

New Genomic Structure for Prostate Cancer Specific Gene PCA3 within BMCC1: Implications for Prostate Cancer Detection and Progression
por: Clarke, Raymond A., et al.
Publicado: (2009)

Overexpression of DA41 in v‐Ha‐ras‐3Y1 Cells Causes Growth Suppression
por: Ozaki, Toshinori, et al.
Publicado: (2000)

Antiproliferative and pro-apoptotic effects afforded by novel Src-kinase inhibitors in human neuroblastoma cells
por: Navarra, Michele, et al.
Publicado: (2010)

The Role of MYCN in Symmetric vs. Asymmetric Cell Division of Human Neuroblastoma Cells
por: Izumi, Hideki, et al.
Publicado: (2020)

The RUNX Family Defines Trk Phenotype and Aggressiveness of Human Neuroblastoma through Regulation of p53 and MYCN
por: Ando, Kiyohiro, et al.
Publicado: (2023)

Tumor suppressor KIF1Bβ regulates mitochondrial apoptosis in collaboration with YME1L1
por: Ando, Koji, et al.
Publicado: (2019)

NCYM, a Cis-Antisense Gene of MYCN, Encodes a De Novo Evolved Protein That Inhibits GSK3β Resulting in the Stabilization of MYCN in Human Neuroblastomas
por: Suenaga, Yusuke, et al.
Publicado: (2014)

Loss of p53 suppresses replication stress-induced DNA damage in ATRX-deficient neuroblastoma
por: Akter, Jesmin, et al.
Publicado: (2021)

Epithelial-mesenchymal transition-related gene expression as a new prognostic marker for neuroblastoma
por: NOZATO, MEGUMI, et al.
Publicado: (2012)

Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma
por: Ho, Wan-Ling, et al.
Publicado: (2016)

Genomic analysis–integrated whole-exome sequencing of neuroblastomas identifies genetic mutations in axon guidance pathway
por: Li, Yuanyuan, et al.
Publicado: (2017)

Correlation of elevated level of blood midkine with poor prognostic factors of human neuroblastomas
por: Ikematsu, S, et al.
Publicado: (2003)

Expression of ret Proto‐oncogene in Human Neuroblastomas
por: Nagao, Minako, et al.
Publicado: (1990)

A novel technique for measuring variations in DNA copy-number: competitive genomic polymerase chain reaction
por: Iwao-Koizumi, Kyoko, et al.
Publicado: (2007)

Sendai virus-mediated expression of reprogramming factors promotes plasticity of human neuroblastoma cells
por: Islam, S M Rafiqul, et al.
Publicado: (2015)

Intracellular expression of toll-like receptor 4 in neuroblastoma cells and their unresponsiveness to lipopolysaccharide
por: Hassan, Ferdaus, et al.
Publicado: (2006)

Tula hantavirus triggers pro-apoptotic signals of ER stress in Vero E6 cells
por: Li, Xiao-Dong, et al.
Publicado: (2005)

CFC1 is a cancer stemness-regulating factor in neuroblastoma
por: Chikaraishi, Koji, et al.
Publicado: (2017)

Sepsis: pro-apoptotic and anti-apoptotic signals in liver cells
por: Chatzigianni, EV, et al.
Publicado: (2002)

Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven Neuroblastoma
por: Zhai, Lei, et al.
Publicado: (2023)

Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report
por: Yamamoto, Hiroyuki, et al.
Publicado: (2018)

Allosteric Sensitization of Pro-Apoptotic BAX
por: Pritz, Jonathan R., et al.
Publicado: (2017)

ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors
por: Parvin, Sultana, et al.
Publicado: (2023)

Serum-Based Quantification of MYCN Gene Amplification in Young Patients with Neuroblastoma: Potential Utility as a Surrogate Biomarker for Neuroblastoma
por: Yagyu, Shigeki, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pja4fau4sek952folkki32diek